Results 161 to 170 of about 244,283 (220)

Un cœur vide. [PDF]

CMAJ
Cragg JJ.
europepmc   +1 more source

Geographical disparities in cancer and occupational exposure to pesticides in a French-West Indies territory (2006-2019). [PDF]

BMC Cancer
Houpert R, Véronique-Baudin J, Almont T, Beaubrun-Renard M, Boullard M, Pierre-Louis A, Vestris M, Ulric-Gervaise S, Montabord C, Macni J, Sylvestre E, Joachim C.   +11 more
europepmc   +1 more source

Bladder Diary Feasibility and Reliability in Neurogenic Lower Urinary Tract Dysfunction Patients. [PDF]

Neurourol Urodyn
Haegel A, Grasland M, Robert H, Pichon B.   +3 more
europepmc   +1 more source

Le Canada à la tête d’un mouvement international en faveur de services d’avortement accessibles et sécuritaires. [PDF]

Can Fam Physician
Paynter M, Norman WV.
europepmc   +1 more source

Functional insulin therapy in type 1 diabetics: Short-term effects on weight and nutritional intake. [PDF]

Tunis Med
Ounaissa K, Madhbouh M, Mahjoub F, Ben Amor N, Abdesselem H, Lahmar I, Gammoudi A, Amrouche C, Jamoussi Kamoun H.   +8 more
europepmc   +1 more source

Long-term functional outcomes and complications of robot-assisted laparoscopic supratrigonal cystectomy with augmentation cystoplasty in adult patients with neurogenic lower urinary tract dysfunction and interstitial cystitis/bladder pain syndrome: A single-centre experience. [PDF]

BJUI Compass
Batard T, Mesnard B, Levesque A, Le Normand L, Perrouin-Verbe B, Rigaud J, Perrouin-Verbe MA.   +6 more
europepmc   +1 more source

Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitors. [PDF]

Immunother Adv
Waeckel L, Talon C, Barrau M, Berger AE, Roblin X, Paul S.   +5 more
europepmc   +1 more source

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin? [PDF]

Cardiol J
Kubica J, Adamski P, Buszko K, Buszman P, Elmasri N, Fabiszak T, Foryś J, Gajda R, Gąsior M, Gil R, Grzelakowski P, Hajdukiewicz T, Jaguszewski M, Kern A, Kochmann W, Konarski J, Kubica A, Kudla T, Kuliczkowski W, Kusińska-Czyczyło A, Laskowska E, Magielski P, Michalski P, Milewski K, Mrzywka N, Niezgoda P, Ostrowska M, Piasecki M, Podhajski P, Prokopczuk J, Ratajczak J, Rzepka-Cholasińska A, Skonieczny G, Specchia G, Szarpak Ł, Szymański P, Topolska M, Umińska JM, Ziółkowski M, Żurakowski A, Navarese EP.   +40 more
europepmc   +1 more source

Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer. [PDF]

Oncologist
Boisteau E, Dahan L, Williet N, Le Malicot K, Desramé J, Bouché O, Petorin C, Malka D, Rebischung C, Aparicio T, Lecaille C, Rinaldi Y, Turpin A, Bignon AL, Bachet JB, Lepage C, Granger V, Legoux JL, Deplanque G, Baconnier M, Lecomte T, Bonnet I, Seitz JF, François E, Lièvre A, PRODIGE 35 Investigator/Collaborators .   +25 more
europepmc   +1 more source